Eva Besemfelder

1.7k total citations
12 papers, 870 citations indexed

About

Eva Besemfelder is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Eva Besemfelder has authored 12 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Hepatology. Recurrent topics in Eva Besemfelder's work include Cancer, Hypoxia, and Metabolism (4 papers), Liver physiology and pathology (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Eva Besemfelder is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Liver physiology and pathology (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Eva Besemfelder collaborates with scholars based in Germany, China and United States. Eva Besemfelder's co-authors include Hellmut G. Augustin, Junhao Hu, Friedrich Marks, Claudia Korn, Gerhard Fürstenberger, Kshitij Srivastava, Markus Thomas, Carolin Mogler, Matthias Wieland and Anja Runge and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Eva Besemfelder

12 papers receiving 852 citations

Peers

Eva Besemfelder
Eva Besemfelder
Citations per year, relative to Eva Besemfelder Eva Besemfelder (= 1×) peers Beatriz Arteta

Countries citing papers authored by Eva Besemfelder

Since Specialization
Citations

This map shows the geographic impact of Eva Besemfelder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Besemfelder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Besemfelder more than expected).

Fields of papers citing papers by Eva Besemfelder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Besemfelder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Besemfelder. The network helps show where Eva Besemfelder may publish in the future.

Co-authorship network of co-authors of Eva Besemfelder

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Besemfelder. A scholar is included among the top collaborators of Eva Besemfelder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Besemfelder. Eva Besemfelder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Gengenbacher, Nicolas, Mahak Singhal, Carolin Mogler, et al.. (2020). Timed Ang2-Targeted Therapy Identifies the Angiopoietin–Tie Pathway as Key Regulator of Fatal Lymphogenous Metastasis. Cancer Discovery. 11(2). 424–445. 21 indexed citations
2.
Singhal, Mahak, Nicolas Gengenbacher, Jingjing Shi, et al.. (2020). Preclinical validation of a novel metastasis‐inhibiting Tie1 function‐blocking antibody. EMBO Molecular Medicine. 12(6). e11164–e11164. 13 indexed citations
3.
Singhal, Mahak, Donato Inverso, Kai Jiang, et al.. (2018). Endothelial cell fitness dictates the source of regenerating liver vasculature. The Journal of Experimental Medicine. 215(10). 2497–2508. 28 indexed citations
4.
Mogler, Carolin, Courtney König, Matthias Wieland, et al.. (2017). Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin. EMBO Molecular Medicine. 9(6). 741–749. 32 indexed citations
5.
Mogler, Carolin, Matthias Wieland, Courtney König, et al.. (2015). Hepatic stellate cell‐expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage. EMBO Molecular Medicine. 7(3). 332–338. 59 indexed citations
6.
Srivastava, Kshitij, Junhao Hu, Claudia Korn, et al.. (2014). Postsurgical Adjuvant Tumor Therapy by Combining Anti-Angiopoietin-2 and Metronomic Chemotherapy Limits Metastatic Growth. Cancer Cell. 26(6). 880–895. 113 indexed citations
7.
Hu, Junhao, Kshitij Srivastava, Matthias Wieland, et al.. (2014). Endothelial Cell-Derived Angiopoietin-2 Controls Liver Regeneration as a Spatiotemporal Rheostat. Science. 343(6169). 416–419. 234 indexed citations
8.
Christian, Sven, Renate Winkler, Iris Helfrich, et al.. (2008). Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel-Associated Mural Cells. American Journal Of Pathology. 172(2). 486–494. 130 indexed citations
9.
Fürstenberger, Gerhard, H. Hagedorn, Eva Besemfelder, et al.. (1991). Characterization of an 8-lipoxygenase activity induced by the phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin in vivo. Journal of Biological Chemistry. 266(24). 15738–15745. 71 indexed citations
10.
Rose‐John, Stefan, G. Fürstenberger, Peter Krieg, et al.. (1988). Differential effects of phorbol esters on c-fos and c-myc and ornithine decarboxylase gene expression in mouse skin in vivo. Carcinogenesis. 9(5). 831–835. 35 indexed citations
11.
Gschwendt, Michael, Gerhard Fürstenberger, Walter Kittstein, et al.. (1986). Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo; identification by 1H-n.m.r. and GC-MS spectroscopy. Carcinogenesis. 7(3). 449–455. 48 indexed citations
12.
Gschwendt, Michael, Friedemann Horn, Walter Kittstein, et al.. (1984). Calcium and phospholipid-dependent protein kinase activity in mouse epidermis cytosol. Stimulation by complete and incomplete tumor promoters and inhibition by various compounds. Biochemical and Biophysical Research Communications. 124(1). 63–68. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026